Tandem Diabetes terminates CCO Mark Novara without cause; last day May 18

TANDEM DIABETES CARE INC

Mark Novara, EVP & Chief Commercial Officer, notified of termination without cause on May 11, 2026.
His last day of employment is scheduled to be May 18, 2026.
Company states its strategy and 2026 goals remain unchanged.
No successor has been announced as of the filing date.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.